Recent issues in breast cancer detection and the premarket approval by the food and drug administration of a US system for breast lesion evaluation: What happened to science?

被引：9
|
作者：
Kopans, DB
机构：
[1] Department of Radiology, Massachusetts General Hospital, Boston, MA 02114
来源：
RADIOLOGY | 1997年 / 202卷 / 02期
关键词：
breast neoplasms; diagnosis; breast; US; Devil's Advocate; ultrasound; (US); utilization;
D O I：
10.1148/radiology.202.2.9015048
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：315 / 316
页数：2
相关论文
共 24 条
  • [1] US Food and Drug Administration Approval Overview in Metastatic Breast Cancer
    Cortazar, Patricia
    Justice, Robert
    Johnson, John
    Sridhara, Rajeshwari
    Keegan, Patricia
    Pazdur, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) : 1705 - 1711
  • [2] US Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer
    Ribeiro, Tatiane Bomfim
    Ribeiro, Adalton
    Rodrigues, Luiza de Oliveira
    Harada, Guilherme
    Nobre, Moacyr Roberto Cuce
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (01) : 20 - 28
  • [3] National comprehensive cancer network recommendations for drugs without US food and drug administration approval in metastatic breast cancer: A cross-sectional study
    Etan, Tal
    Amir, Eitan
    Tibau, Adriane
    Yerushalmi, Rinat
    Moore, Assaf
    Shepshelovich, Daniel
    Goldvaser, Hadar
    CANCER TREATMENT REVIEWS, 2020, 91
  • [4] US Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
    Singh, Harpreet
    Walker, Amanda J.
    Amiri-Kordestani, Laleh
    Cheng, Joyce
    Tang, Shenghui
    Balcazar, Pamela
    Barnett-Ringgold, Kimberly
    Palmby, Todd R.
    Coo, Xianhua
    Zheng, Nan
    Liu, Qi
    Yu, Jingyu
    Pierce, William F.
    Daniels, Selena R.
    Sridhara, Rajeshwari
    Ibrahim, Amna
    Kluetz, Paul G.
    Blumenthal, Gideon M.
    Beaver, Julia A.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 3486 - 3491
  • [5] National comprehensive cancer network (NCCN) recommendations for drugs without US food and drug administration (FDA) approval in metastatic breast cancer: A cross-sectional study
    Etan, Tal
    Amir, Eitan
    Tibau, Adriana
    Yerushalmi, Rinat
    Moore, Assaf
    Shepshelovich, Daniel
    Goldvaser, Hadar
    CANCER RESEARCH, 2021, 81 (04)
  • [6] US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer
    Royce, Melanie
    Mulkey, Flora
    Osgood, Christy
    Bloomquist, Erik
    Amiri-Kordestani, Laleh
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (18) : 3456 - +
  • [7] A US Food and Drug Administration (FDA) pooled analysis of outcomes for bone only metastatic breast cancer (MBC).
    Wedam, Suparna B.
    Beaver, Julia A.
    Amiri-Kordestani, Laleh
    Bloomquist, Erik
    Tang, Shenghui
    Sridhara, Rajeshwari
    Ibrahim, Amna
    Kim, Geoffrey
    Kluetz, Paul Gustav
    McKee, Amy E.
    Pazdur, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] A computer-aided detection system for the evaluation of breast cancer by mammographic appearance and lesion size
    Brem, RF
    Hoffmeister, JW
    Zisman, G
    DeSimio, MP
    Rogers, SK
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (03) : 893 - 896
  • [9] Evaluation of the United States food and drug administration-approved scoring and test system of HER-2 protein expression in breast cancer
    Birner, P
    Oberhuber, G
    Stani, J
    Reithofer, C
    Samonigg, H
    Hausmaninger, H
    Kubista, E
    Kwasny, W
    Kandioler-Eckersberger, D
    Gnant, M
    Jakesz, R
    CLINICAL CANCER RESEARCH, 2001, 7 (06) : 1669 - 1675
  • [10] Benefit of CDK 4/6 inhibition in less common breast cancer subsets: A US Food and Drug Administration pooled analysis
    Gao, Jennifer J.
    Cheng, Joyce
    Bloomquist, Erik
    Schroeder, Robert
    Amiri-Kordestani, Laleh
    Sridhara, Rajeshwari
    Blumenthal, Gideon Michael
    Pazdur, Richard
    Beaver, Julia A.
    Prowell, Tatiana Michelle
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
123